Imaging in Hepatocellular Carcinoma: What's New?

IF 1.5 4区医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Seminars in Ultrasound Ct and Mri Pub Date : 2023-06-01 DOI:10.1053/j.sult.2023.03.002

Giulia Grazzini, Giuditta Chiti, Giulia Zantonelli, Benedetta Matteuzzi, Silvia Pradella, Vittorio Miele

引用次数: 0

Abstract

Hepatocellular carcinoma (HCC) is the most common liver cancer and is one of the uppermost 2 causes of cancer death. About 70%-90% of HCCs develop within a cirrhotic liver. According to the most recent guidelines, the imaging characteristics of HCC on contrast-enhanced Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) are generally satisfactory to make a diagnosis. Recently, new advanced techniques such as contrast-enhanced ultrasound, CT perfusion, Dynamic Contrast-enhanced MRI, diffusion weighted imaging and radiomics have increased the diagnostic accuracy and characterization of HCC. This review illustrates the state of the art and recent advances in non-invasive imaging evaluation of HCC.

查看原文本刊更多论文

肝细胞癌的影像学：有什么新进展？

肝细胞癌（HCC）是最常见的癌症，也是癌症死亡的两大原因之一。大约70%-90%的HCC发生在肝硬化内。根据最新的指南，HCC的对比增强计算机断层扫描（CT）或磁共振成像（MRI）的成像特征通常是令人满意的诊断。近年来，超声造影、CT灌注、动态增强MRI、扩散加权成像和放射组学等新的先进技术提高了HCC的诊断准确性和特征。这篇综述阐述了HCC非侵入性成像评估的现状和最新进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in Ultrasound Ct and Mri 医学-核医学

CiteScore

2.60

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Seminars in Ultrasound, CT and MRI is directed to all physicians involved in the performance and interpretation of ultrasound, computed tomography, and magnetic resonance imaging procedures. It is a timely source for the publication of new concepts and research findings directly applicable to day-to-day clinical practice. The articles describe the performance of various procedures together with the authors'' approach to problems of interpretation.